Dolutegravir rollout for treatment of HIV with a focus on advanced disease and tuberculosis coinfection: findings from rural KwaZulu-Natal, South Africa (2019-2023)
AIDS Res Ther. 2025 Oct 24;22(1):111. doi: 10.1186/s12981-025-00810-z. ABSTRACT BACKGROUND: While Dolutegravir (DTG) containing antiretroviral therapy (ART) has become the preferred regimen for people living …